Feasibility stuydy of S-1 and weekly cisplatin in patients received R0 resection for Stage IIB and III gastric cancer
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000005600
- Lead Sponsor
- Hamamatsu Organization for Oncology Research and Education : HORE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 2) administration contraindication to S-1 and CDDP 3) systemic administration of corticosteroids, flucytosine, phenytoin or warfarin 4) with active infection 5) with drug hypersensitivity 6) other severe complications, such as paralytic ileus, bowel obstruction, interstitial pneumonitis, pulmonary fibrosis, regular use of insulin or uncontrollable diabetes mellitus, arrhythmias, heart failure, liver cirrhosis, and active hepatitis) 7) with water solubility diarrhea 8) pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant 9) men with willing to get pregnant 10)Any other cases who are regarded as inadequate for study enrollment by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method